(Q37610449)

21 August 2017

1 reference

title

Role of IDO in organ transplantation: promises and difficulties (English)

1 reference

21 August 2017

organ transplantation

1 reference

Stefan Löb

1

1 reference

PubMed ID

19811321

21 August 2017

Alfred Königsrainer

series ordinal

2

1 reference

21 August 2017

1 January 2009

1 reference

International Reviews of Immunology

21 August 2017

1 reference

21 August 2017

28

1 reference

21 August 2017

3-4

1 reference

21 August 2017

185-206

1 reference

Long-term problems related to immunosuppression.

21 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Prevention of allogeneic fetal rejection by tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Exploring the mechanism of tryptophan 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Inhibition of T cell proliferation by macrophage tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Tryptophan and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma and tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

The molecular cell biology of interferon-gamma and its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

CTLA-4-Ig regulates tryptophan catabolism in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

The interaction properties of costimulatory molecules revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Modulation of tryptophan catabolism by regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

CTLA4Ig promotes the induction of hematopoietic chimerism and tolerance independently of Indoleamine-2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Costimulation blockade with belatacept in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR class II B7 regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

CD40/CD154 interactions at the interface of tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Mechanisms of suppression by suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Role of IFNγ in Allograft Tolerance Mediated by CD4+CD25+Regulatory T Cells by Induction of IDO in Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Plasmacytoid dendritic cells in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

The immunoregulatory role of IDO-producing human dendritic cells revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Normal development and function of dendritic cells in mice lacking IDO-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Novel action of indoleamine 2,3-dioxygenase attenuating acute lung allograft injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Suppression of cytotoxic and proliferative xenogeneic T-cell responses by transgenic expression of indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Gene therapy for transplantation with viral vectors--how much of the promise has been realised?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Strategies to improve non-viral vectors--potential applications in clinical transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Induction of indoleamine 2,3-dioxygenase in livers following hepatectomy prolongs survival of allogeneic hepatocytes after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Gene therapy. As Gelsinger case ends, gene therapy suffers another blow

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Cell cycle arrest by kynurenine in lens epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

CTLA4Ig ATTENUATES ACCELERATED REJECTION (PRESENSITIZATION) IN THE MOUSE ISLET ALLOGRAFT MODEL1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180902989119

10.1080/08830180902989119

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19811321